Editorial Board
Pharmacognosy Communications is guided by an independent international board. All submissions are handled by a section editor with no conflict of interest and reviewed under a double-anonymized policy.
University of Tokyo, Japan
Editorial correspondence and appeals may be addressed to the Editor-in-Chief through the submission system.
Senior Editorial Team
3 membersSets editorial policy, arbitrates appeals and oversees the double-anonymized review process.
- Deputy Editor
Leila Fischer
KAUST, Saudi Arabia
- Deputy Editor
Pieter Delgado
Seoul National University, South Korea
- Ethics & Integrity Editor
Sofia Iyer
Technische Universität München, Germany
Research integrity, retractions
Associate Editors
0 membersOne handling editor per section, responsible for reviewer selection and decisions.
Advisory Board
Serving on the board
Associate editors serve renewable three-year terms. Nominations, including self- nominations from active reviewers of Pharmacogn. Commn., are reviewed twice a year by the senior editorial team.